News

The defendants named in the lawsuit include Dr Reddy’s Laboratories Limited, Genpharm, Interpharm, Mylan Pharmaceuticals, Ranbaxy Laboratories, Sun India Pharmaceutical Industries, and related companies and subsidiaries thereof. The

In December 2007, Symmetry and DePuy have entered into a supply agreement which requires DePuy to make minimum purchases from the New Bedford facility for a four year

The lawsuit is in response to Impax’s notice to Endo and Penwest, announced on December 17, 2007, advising of the FDA’s acceptance for substantive review, as of November

In December, 2007 BioMS Medical has entered into a global licensing and development agreement granting Lilly exclusive worldwide rights to BioMS Medical’s lead drug, MBP8298, for the treatment

The clinical study will be a first-in-man Phase I, randomized, placebo controlled, dose-escalation, single center study in which the safety and tolerability of escalating doses of AZX100 will

Lace’s Glaid is a revolutionary diagnostic device that utilizes Pattern Electroretinogram (PERG) to provide a visual stimulus that generates electrical responses of the retina to measure the physical

The trial, designed as a safety study, successfully showed that BrachySil, in combination with standard chemotherapy (gemcitabine), was well tolerated with no clinically significant adverse events related to

The study will evaluate the efficacy of WX-671 in combination with the chemotherapeutic agent capecitabine (Xeloda) in patients with HER2-receptor negative metastatic breast cancer. The trial is supported

The newly granted patent includes 32 claims broadly covering compositions and methods, including pharmaceutical compositions, for small interfering RNAs (siRNAs), the molecules that mediate RNAi. The claims cover